Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 31% ± 14% | |
microglial cell | 11 studies | 38% ± 13% | |
macrophage | 11 studies | 31% ± 20% | |
oligodendrocyte | 6 studies | 22% ± 5% | |
myeloid cell | 6 studies | 25% ± 4% | |
monocyte | 4 studies | 25% ± 9% | |
epithelial cell | 3 studies | 32% ± 14% | |
dendritic cell | 3 studies | 20% ± 1% | |
GABAergic neuron | 3 studies | 31% ± 7% | |
glutamatergic neuron | 3 studies | 43% ± 9% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 6% | |
mast cell | 3 studies | 24% ± 3% | |
alveolar macrophage | 3 studies | 35% ± 10% | |
astrocyte | 3 studies | 25% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 32% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4561.64 | 1445 / 1445 | 100% | 81.60 | 183 / 183 |
skin | 100% | 4835.22 | 1809 / 1809 | 100% | 64.00 | 472 / 472 |
thymus | 100% | 7921.83 | 653 / 653 | 100% | 78.08 | 605 / 605 |
brain | 100% | 3960.20 | 2639 / 2642 | 100% | 66.72 | 705 / 705 |
intestine | 100% | 4258.41 | 966 / 966 | 100% | 46.83 | 526 / 527 |
uterus | 100% | 3849.99 | 170 / 170 | 100% | 61.48 | 458 / 459 |
ovary | 100% | 5405.01 | 180 / 180 | 100% | 40.56 | 429 / 430 |
prostate | 100% | 5212.53 | 245 / 245 | 100% | 38.65 | 500 / 502 |
stomach | 100% | 3926.63 | 359 / 359 | 99% | 41.57 | 284 / 286 |
lung | 100% | 5391.88 | 577 / 578 | 99% | 51.98 | 1148 / 1155 |
adrenal gland | 100% | 3300.04 | 258 / 258 | 99% | 32.92 | 228 / 230 |
breast | 100% | 3441.27 | 459 / 459 | 99% | 41.17 | 1106 / 1118 |
bladder | 100% | 4057.38 | 21 / 21 | 99% | 54.84 | 497 / 504 |
kidney | 100% | 3244.88 | 89 / 89 | 98% | 44.35 | 882 / 901 |
pancreas | 88% | 1162.59 | 290 / 328 | 98% | 46.52 | 174 / 178 |
liver | 98% | 2896.86 | 222 / 226 | 87% | 24.20 | 355 / 406 |
adipose | 100% | 3333.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 42.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.67 | 29 / 29 |
spleen | 100% | 5308.27 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 63.64 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 72.78 | 1 / 1 |
blood vessel | 100% | 3153.30 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2934.13 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2341.00 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1763.82 | 852 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097009 | Biological process | energy homeostasis |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0031589 | Biological process | cell-substrate adhesion |
GO_0006091 | Biological process | generation of precursor metabolites and energy |
GO_0008283 | Biological process | cell population proliferation |
GO_1904659 | Biological process | glucose transmembrane transport |
GO_0010887 | Biological process | negative regulation of cholesterol storage |
GO_0045923 | Biological process | positive regulation of fatty acid metabolic process |
GO_0046697 | Biological process | decidualization |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0045662 | Biological process | negative regulation of myoblast differentiation |
GO_0070341 | Biological process | fat cell proliferation |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_1902894 | Biological process | negative regulation of miRNA transcription |
GO_0051546 | Biological process | keratinocyte migration |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0070346 | Biological process | positive regulation of fat cell proliferation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_2000288 | Biological process | positive regulation of myoblast proliferation |
GO_0042060 | Biological process | wound healing |
GO_0015908 | Biological process | fatty acid transport |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0014842 | Biological process | regulation of skeletal muscle satellite cell proliferation |
GO_0030154 | Biological process | cell differentiation |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0043415 | Biological process | positive regulation of skeletal muscle tissue regeneration |
GO_0009062 | Biological process | fatty acid catabolic process |
GO_0008366 | Biological process | axon ensheathment |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0043401 | Biological process | steroid hormone receptor signaling pathway |
GO_0060612 | Biological process | adipose tissue development |
GO_0006915 | Biological process | apoptotic process |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0006629 | Biological process | lipid metabolic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0006006 | Biological process | glucose metabolic process |
GO_0043616 | Biological process | keratinocyte proliferation |
GO_0007566 | Biological process | embryo implantation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0008289 | Molecular function | lipid binding |
GO_0003707 | Molecular function | nuclear steroid receptor activity |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0070539 | Molecular function | linoleic acid binding |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PPARD |
Protein name | Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) Peroxisome proliferative activated receptor, delta, isoform CRA_b (Peroxisome proliferator-activated nuclear receptor beta/delta variant 2) Alternative protein PPARD |
Synonyms | NR1C2 PPARB hCG_17666 |
Description | FUNCTION: Ligand-activated transcription factor key mediator of energy metabolism in adipose tissues . Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the acyl-CoA oxidase gene. Decreases expression of NPC1L1 once activated by a ligand. . |
Accessions | L8EBG7 ENST00000448077.6 [Q03181-3] F1D8S7 Q03181 ENST00000360694.8 [Q03181-1] ENST00000311565.4 [Q03181-1] ENST00000418635.6 [Q03181-4] ENST00000337400.6 [Q03181-2] |